External Control Arms (ECA) are increasingly recognized for their ability to enhance regulatory submissions. By leveraging real-world evidence (RWE), Cytel helps improve the robustness of clinical trial data, making it more likely to be accepted by regulatory bodies. Using ECAs helps to demonstrate the safety and efficacy of treatments, speeding up the approval process.
For more information visit - https://cytel.com/solutions/sp....ecialty-areas/extern
Beğen
Yorum Yap
Paylaş
